Search research articles
Contact Us
Filters
Showing results (311-320 of 344) with videos related to
Page
of 35
Sort By:
Clinical Pharmacokinetics
|
May 15, 2015
The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD
Simon J C Davies, Benoit H Mulsant, Alastair J Flint, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 4, 2008
Medical burden in late-life bipolar and major depressive disorders
Ariel G Gildengers, Ellen M Whyte, Rebecca A Drayer, et al.
Journal of Clinical Psychopharmacology
|
August 17, 2022
Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis
Argyrios Perivolaris, Nicholas J Ainsworth, George S Alexopoulos, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
August 1, 2008
An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients
Ellen M Whyte, Eric J Lenze, Meryl Butters, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 10, 2000
Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms
M Whyte, R Hubbard, R Meliconi, et al.
Journal of Affective Disorders
|
June 18, 2019
Health-related quality of life in remitted psychotic depression<sup>✰</sup>
Kathleen S Bingham, Ellen M Whyte, Benoit H Mulsant, et al.
Journal of Affective Disorders
|
May 23, 2026
Effect of continuation treatment on health-related quality of life in remitted psychotic depression
Ryma A Bendel, George S Alexopoulos, Patricia Marino, et al.
Psychiatry Research
|
September 19, 2024
Predictors of attrition during acute pharmacotherapy of psychotic depression in a clinical trial
Ryma A Ihaddadene, George S Alexopoulos, Patricia Marino, et al.
Journal of Affective Disorders
|
April 5, 2025
Prediction of remission of pharmacologically treated psychotic depression: A machine learning approach
Emily Carter, Samprit Banerjee, George S Alexopoulos, et al.
JAMA Psychiatry
|
February 27, 2020
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial
Aristotle N Voineskos, Benoit H Mulsant, Erin W Dickie, et al.
Page
of 35
Search research articles
Search
Showing results (311-320 of 344) with videos related to
Sort By:
Page
of 35
Clinical Pharmacokinetics
|
May 15, 2015
The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD
Simon J C Davies, Benoit H Mulsant, Alastair J Flint, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 4, 2008
Medical burden in late-life bipolar and major depressive disorders
Ariel G Gildengers, Ellen M Whyte, Rebecca A Drayer, et al.
Journal of Clinical Psychopharmacology
|
August 17, 2022
Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis
Argyrios Perivolaris, Nicholas J Ainsworth, George S Alexopoulos, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
August 1, 2008
An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients
Ellen M Whyte, Eric J Lenze, Meryl Butters, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 10, 2000
Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms
M Whyte, R Hubbard, R Meliconi, et al.
Journal of Affective Disorders
|
June 18, 2019
Health-related quality of life in remitted psychotic depression<sup>✰</sup>
Kathleen S Bingham, Ellen M Whyte, Benoit H Mulsant, et al.
Journal of Affective Disorders
|
May 23, 2026
Effect of continuation treatment on health-related quality of life in remitted psychotic depression
Ryma A Bendel, George S Alexopoulos, Patricia Marino, et al.
Psychiatry Research
|
September 19, 2024
Predictors of attrition during acute pharmacotherapy of psychotic depression in a clinical trial
Ryma A Ihaddadene, George S Alexopoulos, Patricia Marino, et al.
Journal of Affective Disorders
|
April 5, 2025
Prediction of remission of pharmacologically treated psychotic depression: A machine learning approach
Emily Carter, Samprit Banerjee, George S Alexopoulos, et al.
JAMA Psychiatry
|
February 27, 2020
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial
Aristotle N Voineskos, Benoit H Mulsant, Erin W Dickie, et al.
Page
of 35